Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?

Hellenic Journal of Nuclear Medicine

Volumn 20, Issue 1, 2017, Pages 41-45

  Lalosevic, Milica Stojkovic ^a   Stankovic, Sanja ^a   Stojkovic, Mirjana ^a,b   Markovic, Velimir ^b,c   Dimitrijevic, Ivan ^b,c   Lalosevic, Jovan ^a   Petrovic, Jelena ^b   Brankovic, Marija ^b   Markovic, Aleksandra Pavlovic ^a,b   Krivokapic, Zoran ^b,c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Clinic for Digestive Surgery   (Serbia)

Author keywords

Colorectal cancer Liver metastases; Lymph nodes metastases; CA19 9 CEA

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CA 125 ANTIGEN; TUMOR MARKER;

ADULT; ANTIGEN DETECTION; ARTICLE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISTANT METASTASIS; ELECTROCHEMILUMINESCENCE; FEMALE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; MIDDLE AGED; PERINEURAL INVASION; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLOOD; COLORECTAL NEOPLASMS; COMORBIDITY; LIVER NEOPLASMS; PREOPERATIVE CARE; PREVALENCE; REPRODUCIBILITY; RISK FACTOR; SECONDARY; SERBIA; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE;

BIOMARKERS, TUMOR; CA-125 ANTIGEN; CA-19-9 ANTIGEN; COLORECTAL NEOPLASMS; COMORBIDITY; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SERBIA; SURVIVAL RATE;

EID: 85021854110     PISSN: 17905427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Siegel R, Ward E, Brawley O Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-36.
2. Cancer incidence and mortality in central Serbia. Institute of Public He-alth of Serbia "Dr Milan Jovanovic-Batut" Center for prevention and control of noncommunicable diseases. Report No 15. 2015: 21
3. Pakdel A, Malekzadeh M, Naghibalhossaini F. The association between preoperative serum CEA concetrations and synchronous liver metastasis in colorateral cancer patients. Cancer Biomark 2016; 16: 245-52.
4. Heinemann V, von Weikersthal LF, Decker T et al. FOLFIRI plus cetuxi-mab versus FOLFI RI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. Lancet Oncol 2014; 15: 1065-75.
5. McKeown E, Nelson DW, Johnson EK et al. Current approaches and challenges for monitoring treatment response in colon and rectal cancer. J Cancer 2014; 5: 31-43.
6. Duffy MJ, Dalen van A, Haglund C et al. Clinical utility of biochemical markers in colorectal cancer. European Group on Tumor Markers (EG-TM) guidelines. Eur J Cancer 2003; 39: 718-27.
7. Kahi CJ, Anderson JC, Rex DK. Screening and surveillance for colorectal cancer: state of the art. Gastrointest Endosc 2013; 77: 335-50.
8. Hanke B, Riedel C, Lampert S et al. CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative fistline chemotherapy with weekly 24-hour infusion of high-dose 5-fluoracil (5-FU) and folinic acid (FA). Ann Oncol 2001; 12: 221-6.
9. Stiksma J, Grootendorst DC, van der Linden PW. CA 19-9 as a marker in addition to CEA to monitor colorectal cancer. ClinColorectalCancer 2014; 13: 239-44.
10. AJCC (American Joint Committee on Cancer) cancer staging manual, 7th ed, Edge, SB, Byrd, DR, Compton, cc, et al (EDS), Springer, New York 2010. P 143
11. Harrison LE, Guillem JG, Paty P, Cohen AM. Preoperative carcinoem-bryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients. J Am Coll Surg 1997; 185: 55-9.
12. Jeon Bg, Shin R, Chung Jk et al. Individualized cutoff value of the preoperative carcinoembryonic antigen level is necessary for optimal use as a prognostic marker. Annals of Coloproctology 2013; 29 (3):106-14.
13. Nakagoe T, Sawai T, Ayabe H et al. Prognostic value of carcino-embryonic antigen (CEA) in tumor tissue of patients with colorectal cancer. Anticancer Res 2001; 21: 3031-6.
14. Kirat HT, Ozturk E, Lavery IC, Kiran RP. The predictive value of preope-rative carcinoembryonic antigen level in the prognosis of colon cancer. Am J Surg 2012; 204: 447-52.
15. Lin PC, Lin J K, Lin CC et al. Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis. Int J Co-lorectalDis 2012; 27: 1333-8.
16. Wang J, Wang X, Yu F et al. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients. Int J Clin Exp Pathol 2015; 8: 14853-63.
17. Park IJ, Kim HC, Yu CS et al. Cut off values of preoperative s-CEA levels for predicting survivals after curative resection of colorec-tal cancer. J Korean Med Sci 2005; 20: 624-7.
18. Rognum T, Elgjo K, Brandtzaeg P et al. Plasma carcinoembryonic antigen concentrations and immunohistochemical patterns of epithelial marker antigens in patients with large bowel carcinoma. J Clin Pathol 1982; 35: 922-33.
19. Chapman MA, Buckley D, Henson DB, Armitage NC. Preoperative carcinoembryonic antigen is related to tumour stage and longterm sur-vival in colorectal cancer. Br J Cancer 1998; 78: 1346-9.
20. Moertel CG, O'Fallon JR, Go VL et al. The pre-operative carcinoem-bryonic antigen test in the diagnosis, staging and prognosis of colorectal cancer. Cancer 1986; 58: 603-10.
21. Mayer RJ, Garnick MB, Steele GD Jr, Zamcheck N. Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colore-ctal cancer. Cancer 1978; 42: 1428-33.
22. Levy M, Visokai V, Lipska L, Topolcan O. Tumor markers in staging and prognosis of colorectal carcinoma. Neoplasma 2008; 55: 138-42.
23. Polat E, Duman U, Duman M et al. Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 in co-lorectal cancer. Curr Oncol 2014; 21: e1-7.
24. Wang Ws, Lin Jk, Lin Tc et al. EIA versus RIA in detecting carcinoem-bryonic antigen level of patients with metastatic colorectal cancer. Hepatogastroenterology 2004; 51(55):136-41.
25. Al-Shuneigat JM, Mahgoub SS, Huq F. Colorectal carcinoma: nucleoso-mes, carcinoembryonic antigen and CA 19-9 as apoptotic markers; a comparative study. J Biomed Sci 2011; 18: 50.
26. Zheng CX, Zhan WH, Zhao JZ et al. The prognostic value of pre-opera-tive serum levels of CEA, CA19-9 and CA 72-4 in patients with colorec-tal cancer. World J Gastroenterol 2001; 7: 431-4.